Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Long-term follow up after third party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease.

Kazi S, Mathur A, Wilkie G, Cheal K, Battle R, McGowan N, Fraser N, Hargreaves E, Turner D, Campbell JDM, Turner M, Vickers MA.

Haematologica. 2019 Feb 21. pii: haematol.2018.207548. doi: 10.3324/haematol.2018.207548. [Epub ahead of print]

2.

Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation.

Ottaviano G, Chiesa R, Feuchtinger T, Vickers MA, Dickinson A, Gennery AR, Veys P, Todryk S.

Cells. 2019 Jan 14;8(1). pii: E47. doi: 10.3390/cells8010047. Review.

3.

Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the major human platelet autoantigen glycoprotein IIb/IIIa in HLA-transgenic mice.

Hall LS, Lennon CS, Hall AM, Urbaniak SJ, Vickers MA, Barker RN.

Haematologica. 2019 May;104(5):1074-1082. doi: 10.3324/haematol.2017.179424. Epub 2018 Dec 4.

4.

Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens.

Forrester MA, Wassall HJ, Hall LS, Cao H, Wilson HM, Barker RN, Vickers MA.

Cell Immunol. 2018 Oct;332:58-76. doi: 10.1016/j.cellimm.2018.07.008. Epub 2018 Jul 19.

PMID:
30077333
5.

Combined linkage and association analysis of classical Hodgkin lymphoma.

Lawrie A, Han S, Sud A, Hosking F, Cezard T, Turner D, Clark C, Murray GI, Culligan DJ, Houlston RS, Vickers MA.

Oncotarget. 2018 Apr 17;9(29):20377-20385. doi: 10.18632/oncotarget.24872. eCollection 2018 Apr 17.

6.

Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children.

Chiou FK, Beath SV, Wilkie GM, Vickers MA, Morland B, Gupte GL.

Pediatr Transplant. 2018 Mar;22(2). doi: 10.1111/petr.13133. Epub 2018 Feb 1.

PMID:
29388302
7.

Deficiency in Protein Tyrosine Phosphatase PTP1B Shortens Lifespan and Leads to Development of Acute Leukemia.

Le Sommer S, Morrice N, Pesaresi M, Thompson D, Vickers MA, Murray GI, Mody N, Neel BG, Bence KK, Wilson HM, Delibegović M.

Cancer Res. 2018 Jan 1;78(1):75-87. doi: 10.1158/0008-5472.CAN-17-0946. Epub 2017 Nov 9.

8.

Effective antigen presentation to helper T cells by human eosinophils.

Farhan RK, Vickers MA, Ghaemmaghami AM, Hall AM, Barker RN, Walsh GM.

Immunology. 2016 Dec;149(4):413-422. doi: 10.1111/imm.12658. Epub 2016 Sep 20.

9.

Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1.

Khanolkar RC, Kalogeropoulos M, Lawrie A, Roghanian A, Vickers MA, Young NT.

J Leukoc Biol. 2016 Oct;100(4):737-746. Epub 2016 Apr 29.

PMID:
27129285
10.

Intraoperative salvage does not affect expression of markers for erythrophagocytosis.

Chakravarty PD, Porter C, Cao H, Cairns L, Moss M, Duthie R, Ashcroft P, Jeffrey R, Gibson G, Buchan K, Erwig L, Barker RN, Vickers MA.

Transfus Med. 2016 Apr;26(2):147-9. doi: 10.1111/tme.12288. Epub 2016 Mar 22. No abstract available.

PMID:
27000682
11.

Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes.

Naik S, Nicholas SK, Martinez CA, Leen AM, Hanley PJ, Gottschalk SM, Rooney CM, Hanson IC, Krance RA, Shpall EJ, Cruz CR, Amrolia P, Lucchini G, Bunin N, Heimall J, Klein OR, Gennery AR, Slatter MA, Vickers MA, Orange JS, Heslop HE, Bollard CM, Keller MD.

J Allergy Clin Immunol. 2016 May;137(5):1498-1505.e1. doi: 10.1016/j.jaci.2015.12.1311. Epub 2016 Feb 24.

12.

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis.

Ball RJ, Avenell A, Aucott L, Hanlon P, Vickers MA.

Arthritis Res Ther. 2015 Sep 29;17:274. doi: 10.1186/s13075-015-0755-6. Review.

13.

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.

Vickers MA, Wilkie GM, Robinson N, Rivera N, Haque T, Crawford DH, Barry J, Fraser N, Turner DM, Robertson V, Dyer P, Flanagan P, Newlands HR, Campbell J, Turner ML.

Br J Haematol. 2014 Nov;167(3):402-10. doi: 10.1111/bjh.13051. Epub 2014 Jul 26.

14.

Human interleukin-27: wide individual variation in plasma levels and complex inter-relationships with interleukin-17A.

Forrester MA, Robertson L, Bayoumi N, Keavney BD, Barker RN, Vickers MA.

Clin Exp Immunol. 2014 Nov;178(2):373-83. doi: 10.1111/cei.12408.

15.

Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the RhD protein in HLA-transgenic mice.

Hall LS, Hall AM, Pickford W, Vickers MA, Urbaniak SJ, Barker RN.

Haematologica. 2014 Mar;99(3):588-96. doi: 10.3324/haematol.2012.082081. Epub 2014 Jan 17.

16.

Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge.

Whibley N, Maccallum DM, Vickers MA, Zafreen S, Waldmann H, Hori S, Gaffen SL, Gow NA, Barker RN, Hall AM.

Eur J Immunol. 2014 Apr;44(4):1069-83. doi: 10.1002/eji.201343604. Epub 2014 Feb 13.

17.

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus.

Hanlon P, Avenell A, Aucott L, Vickers MA.

Arthritis Res Ther. 2014 Jan 6;16(1):R3. doi: 10.1186/ar4429. Review.

18.

Quantitative variation in plasma angiotensin-I converting enzyme activity shows allelic heterogeneity in the ABO blood group locus.

Terao C, Bayoumi N, McKenzie CA, Zelenika D, Muro S, Mishima M, Connell JM, Vickers MA, Lathrop GM, Farrall M, Matsuda F, Keavney BD; Nagahama Cohort Research Group.

Ann Hum Genet. 2013 Nov;77(6):465-71. doi: 10.1111/ahg.12034. Epub 2013 Aug 13.

20.

Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis.

Almohmeed YH, Avenell A, Aucott L, Vickers MA.

PLoS One. 2013 Apr 9;8(4):e61110. doi: 10.1371/journal.pone.0061110. Print 2013. Review.

21.

The soluble isoform of CTLA-4 as a regulator of T-cell responses.

Ward FJ, Dahal LN, Wijesekera SK, Abdul-Jawad SK, Kaewarpai T, Xu H, Vickers MA, Barker RN.

Eur J Immunol. 2013 May;43(5):1274-85. doi: 10.1002/eji.201242529. Epub 2013 Mar 6.

22.

Acute myeloid leukemia presenting in a mother and daughter pair with the identical acquired karyotypic abnormality consisting of inversion 3q21q26 and monosomy 7: a review of possible mechanisms.

Lawrie A, Stevenson DA, Doig TN, Vickers MA, Culligan DJ.

Cancer Genet. 2012 Nov;205(11):599-602. doi: 10.1016/j.cancergen.2012.09.001. Epub 2012 Oct 12.

PMID:
23064135
23.

Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune function.

Milliken SV, Wassall H, Lewis BJ, Logie J, Barker RN, Macdonald H, Vickers MA, Ormerod AD.

J Allergy Clin Immunol. 2012 Jun;129(6):1554-61. doi: 10.1016/j.jaci.2012.03.001. Epub 2012 Apr 12.

PMID:
22502796
24.

Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen.

Stephen J, Cairns LS, Pickford WJ, Vickers MA, Urbaniak SJ, Barker RN.

Blood. 2012 Jun 7;119(23):5563-74. doi: 10.1182/blood-2012-02-410324. Epub 2012 Apr 5.

25.

Production of the effector cytokine interleukin-17, rather than interferon-γ, is more strongly associated with autoimmune hemolytic anemia.

Hall AM, Zamzami OM, Whibley N, Hampsey DP, Haggart AM, Vickers MA, Barker RN.

Haematologica. 2012 Oct;97(10):1494-500. doi: 10.3324/haematol.2011.060822. Epub 2012 Mar 14.

26.

Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults.

Crowther M, Chan YL, Garbett IK, Lim W, Vickers MA, Crowther MA.

Blood. 2011 Oct 13;118(15):4036-40. doi: 10.1182/blood-2011-05-347708. Epub 2011 Jul 21. Review. No abstract available.

27.

Helper T cells point the way to specific immunotherapy for autoimmune disease.

Hall AM, Vickers MA, Barker RN, Erwig LP.

Cardiovasc Hematol Disord Drug Targets. 2009 Sep;9(3):159-66. Review.

PMID:
19534656
28.

A case of apples and pears?

Crowther M, Vickers MA, Avenell A.

Blood. 2009 Jun 11;113(24):6259-60; author reply 6260. doi: 10.1182/blood-2009-03-211169. No abstract available.

29.

Novel genetic variants linked to coronary artery disease by genome-wide association are not associated with carotid artery intima-media thickness or intermediate risk phenotypes.

Cunnington MS, Mayosi BM, Hall DH, Avery PJ, Farrall M, Vickers MA, Watkins H, Keavney B.

Atherosclerosis. 2009 Mar;203(1):41-4. doi: 10.1016/j.atherosclerosis.2008.06.025. Epub 2008 Jul 3.

30.

Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma.

Mittal S, Marshall NA, Duncan L, Culligan DJ, Barker RN, Vickers MA.

Blood. 2008 Jun 1;111(11):5359-70. doi: 10.1182/blood-2007-08-105395. Epub 2008 Feb 27.

31.

A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura.

Mittal S, Blaylock MG, Culligan DJ, Barker RN, Vickers MA.

Haematologica. 2008 Jan;93(1):151-2. doi: 10.3324/haematol.11822.

32.

ABO(H) blood groups and vascular disease: a systematic review and meta-analysis.

Wu O, Bayoumi N, Vickers MA, Clark P.

J Thromb Haemost. 2008 Jan;6(1):62-9. Epub 2007 Oct 25.

33.
34.

Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia.

Ward FJ, Hall AM, Cairns LS, Leggat AS, Urbaniak SJ, Vickers MA, Barker RN.

Blood. 2008 Jan 15;111(2):680-7. Epub 2007 Aug 30.

35.

Immunomodulation against leukemias and lymphomas: a realistic future treatment?

Mittal S, Marshall NA, Barker RN, Vickers MA.

Crit Rev Oncol Hematol. 2008 Feb;65(2):101-8. Epub 2007 Aug 23. Review.

PMID:
17719232
36.

Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7 F status, clonality, and antiphospholipid antibodies.

Robertson B, Urquhart C, Ford I, Townend J, Watson HG, Vickers MA, Greaves M.

J Thromb Haemost. 2007 Aug;5(8):1679-85. Epub 2007 May 21.

38.

The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.

Marshall NA, Culligan DJ, Tighe J, Johnston PW, Barker RN, Vickers MA.

Exp Hematol. 2007 Apr;35(4):596-604.

PMID:
17379070
39.

Controlling autoimmunity--Lessons from the study of red blood cells as model antigens.

Barker RN, Vickers MA, Ward FJ.

Immunol Lett. 2007 Jan 15;108(1):20-6. Epub 2006 Nov 13. Review.

PMID:
17134764
40.

X inactivation patterns of closely, but not distantly, related cells are highly correlated: little evidence for stem cell plasticity in normal females.

Vickers MA, Canning SJ, Craig WL, Masson NM, Wilson IJ.

Stem Cells. 2006 Nov;24(11):2398-405. Epub 2006 Jul 6.

41.

The effectiveness of screening for prostate cancer: a nested case-control study.

Concato J, Wells CK, Horwitz RI, Penson D, Fincke G, Berlowitz DR, Froehlich G, Blake D, Vickers MA, Gehr GA, Raheb NH, Sullivan G, Peduzzi P.

Arch Intern Med. 2006 Jan 9;166(1):38-43.

PMID:
16401808
42.

Pyoderma gangrenosum as a cause of splenomegaly and association with a T-cell clone.

Mittal S, Milner BJ, Vickers MA.

Clin Lab Haematol. 2005 Dec;27(6):402-4.

PMID:
16307544
43.

Non-fatal haemophagocytic syndrome in an elderly patient.

Soiza RL, Ghosh S, McAlpine JK, Vickers MA.

Age Ageing. 2005 Sep;34(5):522-4.

PMID:
16107462
44.

The relationships of ABO, Lewis and Secretor blood groups with cerebral ischaemia of arterial origin.

Clark P, Meiklejohn DJ, O'Sullivan A, Vickers MA, Greaves M.

J Thromb Haemost. 2005 Sep;3(9):2105-8. No abstract available.

45.

The procoagulant potential of environmental particles (PM10).

Gilmour PS, Morrison ER, Vickers MA, Ford I, Ludlam CA, Greaves M, Donaldson K, MacNee W.

Occup Environ Med. 2005 Mar;62(3):164-71.

46.

Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells.

Hall AM, Vickers MA, McLeod E, Barker RN.

Blood. 2005 Mar 1;105(5):2007-15. Epub 2004 Jul 29.

47.

Autologous tunica vaginalis and subcapsular orchiectomy: a hormonal therapy for prostate cancer.

Vickers MA Jr, Lamontagne DP, Guru KA, Satyanarayana RK, Vickers KE, Menon M.

J Androl. 2004 May-Jun;25(3):375-81.

48.

Erectile dysfunction in the patient with diabetes mellitus.

Vickers MA, Wright EA.

Am J Manag Care. 2004 Jan;10(1 Suppl):S3-11; quiz S12-6. Review. No abstract available.

49.

Pulmonary and systemic effects of short-term inhalation exposure to ultrafine carbon black particles.

Gilmour PS, Ziesenis A, Morrison ER, Vickers MA, Drost EM, Ford I, Karg E, Mossa C, Schroeppel A, Ferron GA, Heyder J, Greaves M, MacNee W, Donaldson K.

Toxicol Appl Pharmacol. 2004 Feb 15;195(1):35-44.

PMID:
14962503
50.

Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma.

Munro LR, Johnston PW, Marshall NA, Canning SJ, Hewitt SG, Tveita K, Vickers MA.

Leuk Lymphoma. 2003 Dec;44(12):2083-8.

PMID:
14959851

Supplemental Content

Loading ...
Support Center